In general terms, breast cancer is classified into molecular subtypes, such as Luminal A, Luminal B, HER2-enriched and Basal-like, each one characterized by specific gene expression patterns, clinical outcomes and responses to treatment [3,4]. This evidence concerns the gene ERBB2 and breast carcinoma.